In this study, researchers found no significant improvement in SDFT injuries treated with mesenchymal stem cells compared to those treated with a simple bone marrow supernatant.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In